Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

HLA ANTIBODIES

Clinical trials for HLA ANTIBODIES explained in plain language.

Never miss a new study

Get alerted when new HLA ANTIBODIES trials appear

Sign up with your email to follow new studies for HLA ANTIBODIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1
Sort by
  • New combo aims to fix transfusion failure in blood cancer patients

    Disease control Not yet recruiting

    This phase 3 trial tests whether acalabrutinib (a BTK inhibitor) alone or with bortezomib can lower harmful HLA antibodies that cause platelet transfusions to fail in blood cancer patients. About 42 adults with platelet transfusion refractoriness and high antibody levels will be …

    Matched conditions: HLA ANTIBODIES

    Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

    Last updated Jun 27, 2026 13:04 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space